Ligandal

San Francisco, United States· Est. 2014

AI-powered targeting peptides for lipid nanoparticles and mRNA delivery. 80+ global patents. Founded 2014.

Private Company

Total funding raised: $1.4M

About

AI-powered targeting peptides for lipid nanoparticles and mRNA delivery. 80+ global patents. Founded 2014.

Drug DeliveryNanotechnologyRNA & Gene Therapy

Funding History

2

Total raised:$1.4M

Grant$250KNational Science FoundationSep 15, 2021

Seed$1.2MUndisclosedMar 15, 2020

More companies in Drug Delivery & Formulation →More companies in United States →